Drawing for MEDFACE

USPTO serial 86472837

MEDFACE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MORRIS, KRISTINA KLOIBER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDFACE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander JSW Johnson

ALEXANDER JSW JOHNSON HAMILTON IP LAW, PC2322 E Kimberly Rd235WDAVENPORT, IA 52807

Goods and services

ClassDescriptionStatusFirst use
044Medical services provided via the internet or telecommunication networks, namely, monitoring, mitigation, and treatment of migraine, headache, photosensitivity, neurological, ocular, and vision-related conditions; Medical services, namely, advice, monitoring, mitigation, and treatment of migraine, headache, photosensitivity, neurological, ocular, and vision-related conditions; Multi-disciplinary, integrative, outpatient healthcare and medical consultation services, namely, monitoring, mitigation, and treatment of migraine, headache, photosensitivity, neurological, ocular, and vision-related conditions; Medical screening services, namely, monitoring, mitigation, and treatment of migraine, headache, photosensitivity, neurological, ocular, and vision-related conditions; Medical diagnostic testing, monitoring and reporting services for the treatment of migraine, headache, photosensitivity, neurological, ocular, and vision-related conditions; Medical evaluation services, namely, monitoring, mitigation, and treatment of migraine, headache, photosensitivity, neurological, ocular, and vision-related conditions; Medical services via the internet or telecommunication networks in the fields of migraine, headache, photo-sensitivity, neurological conditions, ocular and vision-related conditions, and monitoring, mitigation, and treatment services related thereto; Medical advice in the fields of migraine, headache, photo-sensitivity, neurological conditions, ocular and vision-related conditions, and monitoring, mitigation, and treatment services related thereto; Multi-disciplinary, integrative, outpatient health care delivery and medical consultations in the fields of migraine, headache, photo-sensitivity, neurological conditions, ocular and vision-related conditions, and monitoring, mitigation, and treatment services related thereto; Medical screening services in the fields of migraine, headache, photo-sensitivity, neurological conditions, ocular and vision-related conditions, and monitoring, mitigation, and treatment services related thereto; Medical diagnostic testing, monitoring and reporting services in the fields of migraine, headache, photo-sensitivity, neurological conditions, ocular and vision-related conditions, and monitoring, mitigation, and treatment services related thereto; Medical evaluation in the fields of migraine, headache, photo-sensitivity, neurological conditions, ocular and vision-related conditions, and monitoring, mitigation, and treatment services related theretoACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 27, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 27, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 10, 2018EX5GSOU EXTENSION 5 GRANTED—
Jan 4, 2018EXT5SOU EXTENSION 5 FILED—
Jan 4, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 27, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 25, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 21, 2017EX4GSOU EXTENSION 4 GRANTED—
Jul 21, 2017EXT4SOU EXTENSION 4 FILED—
Jul 21, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 10, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 6, 2017EX3GSOU EXTENSION 3 GRANTED—
Jan 6, 2017EXT3SOU EXTENSION 3 FILED—
Jan 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 9, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 8, 2016EX2GSOU EXTENSION 2 GRANTED—
Aug 5, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 7, 2016EXT2SOU EXTENSION 2 FILED—
Jul 7, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 5, 2016EXT1SOU EXTENSION 1 FILED—
Jan 5, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 26, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 26, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 20, 2015ALIEASSIGNED TO LIE—
Mar 27, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Mar 27, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 27, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 27, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 20, 2015DOCKASSIGNED TO EXAMINER—
Dec 12, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Dec 11, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance